First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease
- 30 July 2001
- Vol. 19 (31) , 4536-4543
- https://doi.org/10.1016/s0264-410x(01)00184-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Virus Taxonomy – San Diego 1998Archiv für die gesamte Virusforschung, 1998
- IMPACT OF VIRAL HEMORRHAGIC DISEASE ON A WILD POPULATION OF EUROPEAN RABBITS IN FRANCEJournal of Wildlife Diseases, 1998
- Myxoma virus in rabbitsRevue Scientifique et Technique de l'OIE, 1998
- THE INITIAL IMPACT OF RABBIT HEMORRHAGIC DISEASE ON EUROPEAN RABBIT POPULATIONS IN SOUTH AUSTRALIAJournal of Wildlife Diseases, 1998
- A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection.Journal of General Virology, 1997
- Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculusLaboratory Animals, 1997
- Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic diseaseArchiv für die gesamte Virusforschung, 1996
- Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virusVaccine, 1996
- Incidence of viral hemorrhagic disease in wild rabbit populations in SpainMammalia, 1995
- Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89)Journal of General Virology, 1994